Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer

NCT: NCT03277469 · ACTIVE_NOT_RECRUITING

NCT IDNCT03277469
StatusACTIVE_NOT_RECRUITING
Start Date2017-11-13
Completion2027-09-15

Brief Summary

The aim of this study is to develop new tools using magnetic resonance imaging (MRI) that will improve the brachytherapy procedure and treatment for participants with gynecologic cancer.

Frequently Asked Questions

What is Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer?

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer is a clinical trial registered under NCT03277469. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT03277469?

The current status of NCT03277469 (Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer) is: ACTIVE_NOT_RECRUITING.

When did Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer start?

Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer started on 2017-11-13.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑